Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 8:13:808440.
doi: 10.3389/fphar.2022.808440. eCollection 2022.

Effect of 0.01% Atropine on Accommodation in Myopic Teenagers

Affiliations

Effect of 0.01% Atropine on Accommodation in Myopic Teenagers

Huixia Li et al. Front Pharmacol. .

Abstract

Purpose: The purpose of the study is to evaluate the effects of 0.01% atropine eye drops on accommodative system parameters among teenagers with low myopia. Methods: Ninety-five myopic teenagers [39 boys (8.69 ± 2.473) and 56 girls (8.54 ± 2.054) aged 5-17 years] with no history of eye disease were enrolled. Biometric and accommodative system parameters were evaluated before and at 1 week, 1 month, 3 months, and 6 months of 0.01% atropine eye drop instillation. Results: Participants without accommodative demand at 6 months demonstrated insignificant changes after the atropine instillation (all p > 0.05). Nevertheless, there were significant differences in accommodative sensitivity, accommodative amplitude, accommodative responsiveness, and negative relative accommodation (NRA) at 3 months compared with baseline after atropine instillation (all p < 0.05). Except spherical equivalent refraction, cornea thickness, intraocular pressure, and axial length were stable after the 0.01% atropine instillation (all p > 0.05). Conclusion: Morphologically, current measurements suggested that 0.01% atropine had favorable reduction of accommodation for childhood low myopia over a half-year period.

Keywords: accommodation; axial length; low-concentration atropine; myopia; ocular biometric components; spherical equivalent.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Change in biometric parameters after the instillation of 0.01% atropine eye drops. (A) Spherical equivalent. (B) Axial length. (C) Cornea thickness. (D) Intraocular pressure.
FIGURE 2
FIGURE 2
Change in accommodative system parameters after the instillation of 0.01% atropine eye drops. (A) Accommodative sensitivity. (B) Accommodative amplitude. (C) Accommodative response. (D) NRA, negative relative accommodation. (E) PRA, positive relative accommodation. (F) AC/A, accommodative convergence/accommodation ratio.

References

    1. Azuara-Blanco A., Logan N., Strang N., Saunders K., Allen P. M., Weir R., et al. (2020). Low-dose (0.01%) Atropine Eye-Drops to Reduce Progression of Myopia in Children: a Multicentre Placebo-Controlled Randomised Trial in the UK (CHAMP-UK)-study Protocol. Br. J. Ophthalmol. 104 (7), 950–955. 10.1136/bjophthalmol-2019-314819 - DOI - PubMed
    1. Chen D. X., He X. G., Xu X. (2021). The Safety of Atropine for Myopia Prevention and Control. Zhonghua Yan Ke Za Zhi 57 (4), 299–304. 10.3760/cma.j.cn112142-20200622-00413 - DOI - PubMed
    1. Chen M., Long Q., Gu H., Hong J. (2019). Accommodation Changes after Visian Implantable Collamer Lens with central Hole for High Myopia: A STROBE-Compliant Article. Medicine (Baltimore) 98 (28), e16434. 10.1097/MD.0000000000016434 - DOI - PMC - PubMed
    1. Chia A., Chua W. H., Cheung Y. B., Wong W. L., Lingham A., Fong A., et al. (2012). Atropine for the Treatment of Childhood Myopia: Safety and Efficacy of 0.5%, 0.1%, and 0.01% Doses (Atropine for the Treatment of Myopia 2). Ophthalmology 119 (2), 347–354. 10.1016/j.ophtha.2011.07.031 - DOI - PubMed
    1. Chia A., Chua W. H., Wen L., Fong A., Goon Y. Y., Tan D. (2014). Atropine for the Treatment of Childhood Myopia: Changes after Stopping Atropine 0.01%, 0.1% and 0.5%. Am. J. Ophthalmol. 157 (2), 451–e1 e451. 10.1016/j.ajo.2013.09.020 - DOI - PubMed

LinkOut - more resources